T cells that remember a previously encountered virus are essential in establishing protective immunity. But some T cells have a longer lifetime, and thus effectively a longer immunological memory, than others. Work by Riou et al. (page 79) might explain why effector memory T cells (T~EM~) are short lived, whereas central memory T cells (T~CM~) are maintained in the body long-term.

Figure 1IL-2-- and IL-7--induced phosphorylation of FOXO3a (top) may promote survival of T~CM~.

The longer-lived T~CM~ mainly reside in secondary lymphoid organs such as the lymph nodes, whereas the T~EM~ are found in the peripheral tissues and sites of infection. The exact ontogeny of the two cell types is unknown, but it\'s thought that T~CM~ might give rise to the more transient T~EM~ fighters. Regardless of origin, the biological basis for their different life spans was unknown.

Dendritic cells (DCs) were a good starting point, as they are known to produce the T cell survival factor IL-7. The team added dendritic cells to the two memory cell populations and found that the T~CM~ proliferation response was more vigorous, perhaps because IL-7 (and IL-2) more efficiently activated the pro-survival factor STAT5 in T~CM~.

Even without DCs, T~CM~ were less susceptible to apoptosis. These cells had less active pro-apoptotic transcription factor FOXO3a and lower transcription of its targets. FOXO3a activity is inhibited by phosphorylation, and adding IL-7 or IL-2 to the T~CM~ increased FOXO3a phosphorylation at a particular residue, suggesting these cytokines might promote the long-term survival of T~CM~ by both increasing proliferation and decreasing death. ![](jem_iti_end.jpg)
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